Peptides Overview of Potential Applications of Controlling Metaflammation, Metabolic Signaling and its Innate Value in Treatment | 0.5 hr
James LaValle, RPh, CCN, MT, DHM, DHPh
FDA, Quality Assurance, and State to State Status: Where Are We Now and Where Is It Going? | 1.0 hr
Melissa Stefko, MBA, MS, RAC, ASQ CQA
Legal Considerations of Peptides: Best Practices and Managing Risk | 1.0 hr
Melissa Stefko, MBA, MS, RAC, ASQ CQA
Manufacturing of Sterile Product Quality Control: Understanding the “For Human Use Difference” | 1.0 hr
Anthony Campbell, PharmD, BCSCP
Manufacturing of Sterile Product Quality Control: Understanding the “For Human Use Difference” Continued | 1.0 hr
Anthony Campbell, PharmD, BCSCP
Global Lifestyle Considerations in Peptide Medicine | 1.5 hr
James LaValle, RPh, CCN, MT, DHM, DHPh
Integrating Peptides into Clinical Practice | 1.0 hr
Erika Schwartz, MD
SARMS - What are They: The Science and Controversy | 1.0 hr
James LaValle, RPh, CCN, MT, DHM, DHPh
Hormone Signaling and Hormone Receptor Modulation | 2.0 hr
Marisol Duque, MD
All Roads of Health Lead to Immune Modulation and Gut Repair | 2.0 hr
Suzanne Feree Turner, MD, FAARM, ABAARM
The Role of Peptides in Glucose and Insulin Regulation-Balancing the Seesaw | 1.0 hr
James LaValle, RPh, CCN, MT, DHM, DHPh
Intro to Brain Inflammation and Autoimmune | 1.0 hr
Andrew Heyman, MD, MHSA
Intro to Brain Inflammation and Autoimmune cont. | 1.0 hr
Andrew Heyman, MD, MHSA
How to optimize the body to heal from injury using the lens of connective tissue in repair of muscles and organ tissue | 1.5 hr
Kathleen O’Neil-Smith, MD
Cellular Senescence: What contributes to DNA damage and how to optimize cellular health: telomeres, senescence, and zombie cells connection | 1.0 hr
Kathleen O’Neil-Smith, MD
Body Composition and Metabolism Optimization-How to Properly Use Peptides in the Quest of Metabolic Resiliency HGH and Precursor Peptides | 1.5 hr
Gordon Crozier, DO
Body Composition and Metabolism Optimization-How to Properly Use Peptides in the Quest of Metabolic Resiliency HGH and Precursor Peptides | 1.5 hr
Gordon Crozier, DO
Patient Cases | 1.0 hr
Faculty lead by James LaValle, RPh, CCN, MT, DHM, DHPh